Interaction of thrombospondin with resting and stimulated human platelets
- PMID: 3084490
Interaction of thrombospondin with resting and stimulated human platelets
Abstract
The interaction of isolated and radioiodinated thrombospondin with washed human platelets has been characterized. The ligand bound to nonstimulated and thrombin-stimulated platelets in a time-dependent manner, and apparent steady state was reached within 25 min. Binding was not due to iodination of the ligand and was inhibited by nonlabeled thrombospondin but not by unrelated proteins, and bound ligand was identical with thrombospondin in terms of subunit structure. Nonlinear curve-fitting analyses of binding to resting platelets suggested the presence of a single class of sites which bound 3,100 +/- 1,000 molecules/platelet with an apparent Kd of 50 +/- 20 nM. This interaction was not attributable to contaminating cells or inadvertant platelet activation. Binding to thrombin-stimulated platelets had a lower apparent affinity (Kd = 250 +/- 100 nM) and higher apparent capacity (35,600 +/- 9,600 molecules/platelet). Thrombin-enhanced binding was dependent upon agonist dose and platelet stimulation. Fibrinogen, a monoclonal antibody to GPIIb-IIIa, temperature, and divalent ions had differential effects upon thrombospondin binding to resting and stimulated platelets, suggesting the presence of two distinct mechanisms of thrombospondin binding to platelets. While thrombospondin binding to thrombin-stimulated platelets occurs with characteristics similar to those observed for fibrinogen, fibronectin, and von Willebrand Factor, its high affinity interaction with resting platelets is unique to this adhesive glycoprotein.
Similar articles
-
Identification of a new class of inducible receptors on platelets. Thrombospondin interacts with platelets via a GPIIb-IIIa-independent mechanism.J Clin Invest. 1986 Dec;78(6):1713-6. doi: 10.1172/JCI112767. J Clin Invest. 1986. PMID: 3782477 Free PMC article.
-
Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.Eur J Biochem. 1988 Jan 15;171(1-2):383-92. doi: 10.1111/j.1432-1033.1988.tb13802.x. Eur J Biochem. 1988. PMID: 3338471
-
Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human platelets.Blood. 1985 Sep;66(3):724-7. Blood. 1985. PMID: 3875376
-
Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton.J Lab Clin Med. 1991 Nov;118(5):446-57. J Lab Clin Med. 1991. PMID: 1940585
-
The structural and functional properties of thrombospondin.Blood. 1986 May;67(5):1197-209. Blood. 1986. PMID: 3516249 Review. No abstract available.
Cited by
-
Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains.J Cell Biol. 1987 Nov;105(5):2409-15. doi: 10.1083/jcb.105.5.2409. J Cell Biol. 1987. PMID: 3680388 Free PMC article.
-
The postmortem activation status of platelets.Int J Legal Med. 1994;107(3):111-7. doi: 10.1007/BF01225596. Int J Legal Med. 1994. PMID: 7534469
-
Interaction of thrombospondin with platelet glycoproteins GPIa-IIa and GPIIb-IIIa.Biochem J. 1993 Nov 1;295 ( Pt 3)(Pt 3):725-30. doi: 10.1042/bj2950725. Biochem J. 1993. PMID: 8240284 Free PMC article.
-
The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins.J Cell Biol. 1986 Nov;103(5):1635-48. doi: 10.1083/jcb.103.5.1635. J Cell Biol. 1986. PMID: 2430973 Free PMC article.
-
Interaction of von Willebrand factor with blood cells in flow models: a systematic review.Blood Adv. 2022 Jul 12;6(13):3979-3990. doi: 10.1182/bloodadvances.2021006405. Blood Adv. 2022. PMID: 35816358 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases